PharmaEssentia Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 5,105.62 million compared to TWD 2,882.04 million a year ago. Net loss was TWD 623.84 million compared to TWD 1,374.81 million a year ago.

Basic loss per share from continuing operations was TWD 1.93 compared to TWD 4.84 a year ago.